Jen and Rebecca has been / is going nuts for having that asset and these 2 ladies are top experts, why isn't Hopper able to attract big pharma, now a big obstacle taken out of the way. I am not talking a $billion offer like after ph2 but nobody coughing up a lousy AUD 100m / USD 65m makes me thinking whether we or they are the idiots.
This is much easier to sell to big pharma than a fridge to eskimos and believe me, most of them got one.
GLTA
- Forums
- ASX - By Stock
- Ann: First patient dosed in Phase 1/2 trial of CHM CDH17
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Jen and Rebecca has been / is going nuts for having that asset...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.79K | 17.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9548289 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9548289 | 12 |
0.005 | 14771167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online